From their first commercialisation in the mid-1990s, genetically engineered crops (also known as “transgenic” or “genetically modified” plants) have been approved for commercial release in an increasing number of countries, for planting or for entering in the composition of foods and feeds, or use in industrial processing. Up to now, the large majority of these agricultural productions remain for soybean, maize, cotton and rapeseed (canola), as outlined in The Bioeconomy to 2030: Designing a Policy Agenda (OECD, 2009). Despite some differences in total estimates, all analyses and statistics concur in underlining the general increasing trend in volumes produced and traded, number of countries involved and growth potential. For instance, James reports in the Global Status of Commercialized Biotech/GM Crops: 2014, ISAAA Brief No. 49 that the surface area of transgenic crops worldwide constantly increased over the 19-year-period from 1996 to 2014, to reach 181.5 million hectares grown in 28 countries. To date, genetically engineered varieties of over 25 different plant species (including crops, flowers and trees) have received regulatory approval in OECD and non-OECD countries from all regions of the world. Such approvals for release in the environment usually follow a science-based risk/safety assessment before being granted.